Do not assume BP 190/112 caused the seizure—or dismiss it as a postictal spike. In a transplant recipient awaiting tissue diagnosis, a new generalized seizure with reduced responsiveness and marked hypertension raises concern for acute neurologic target-organ injury, including posterior reversible encephalopathy syndrome (PRES). Seizure and airway stabilization, urgent brain imaging, and deliberate pressure management belong in parallel; biopsy is a separate question.
That is a working frame, not a diagnosis. The pressure might contribute to brain injury, reflect seizure-related autonomic activation, or accompany another process. The mistake is to decide which explanation is true from one measurement.
The pressure is a clue, not the diagnosis
Hypertensive emergency means severe blood-pressure elevation with acute target-organ injury; the number alone does not establish it. Under the 2025 U.S. adult guideline, severe-range blood pressure is systolic above 180 mm Hg and/or diastolic above 120 mm Hg; 190/112 meets the threshold by systolic. Here, new neurologic symptoms make acute brain injury a serious concern, but they do not prove that hypertension caused the seizure.
A convulsion can temporarily alter autonomic activity and blood pressure. Hemorrhage, ischemia, an intracranial lesion, infection, medication toxicity, or metabolic disturbance can also cause a seizure and impaired responsiveness. Repeat the pressure after the convulsion settles, compare it with the patient’s usual readings when available, and keep the neurologic assessment moving rather than waiting to see whether the number normalizes.
PRES belongs high in the differential because hypertension, kidney dysfunction, transplantation, and immunosuppressive drugs are recognized associations. The leading models involve impaired cerebral autoregulation and endothelial or blood–brain barrier dysfunction, producing vasogenic edema. PRES is a clinical-radiologic syndrome—not a diagnosis made from the blood pressure and seizure alone. It is not always confined to the posterior brain, and the word reversible is not a promise of full recovery.
| Finding | What it should prompt | What it does not prove |
|---|---|---|
| Severe pressure with new encephalopathy or seizure | Urgent evaluation for acute target-organ injury and monitored care | That hypertension is the sole cause |
| Transplant status or calcineurin-inhibitor exposure | Consider PRES and medication-related neurotoxicity | That the drug level is excessive or the drug is definitely responsible |
| Bilateral, often posterior, FLAIR signal with features of vasogenic edema | Consider PRES in the clinical context | A unique imaging signature; other diagnoses can overlap |
Stabilize and image before naming the process
If a seizure is ongoing or recurs, treat it promptly according to the applicable protocol while supporting airway, breathing, and circulation. Check bedside glucose and assess oxygenation, ventilation, responsiveness, and focal findings. With persistent reduced responsiveness and a need for acute blood-pressure treatment, use a closely monitored setting and repeat the neurologic examination after stabilization.
Obtain urgent brain imaging; do not wait for tissue diagnosis. CT is often the first study when rapid assessment is needed, particularly to identify hemorrhage or mass effect. MRI better characterizes suspected PRES: FLAIR sequences show edema, while diffusion-weighted imaging and apparent diffusion coefficient maps help assess whether the pattern is vasogenic or suggests ischemia. These are supportive patterns, not a standalone diagnostic rule. PRES can have atypical distributions, and stroke, infection, malignancy, and other conditions may overlap clinically or radiologically.
Check relevant metabolic and systemic contributors, including renal function and electrolytes such as magnesium, guided by the presentation. A seizure can leave the patient temporarily less responsive, but do not let that explanation replace serial reassessment or investigation for another acute cause.
Lower pressure without starving the brain
When acute neurologic target-organ injury is suspected, treat the situation as a potential hypertensive emergency while the cause is being clarified. Use close monitoring and, when appropriate, a titratable intravenous agent such as nicardipine or labetalol according to local protocol and the patient’s comorbidities. Avoid abrupt swings and do not aim for a normal blood pressure immediately.
For suspected hypertensive encephalopathy or PRES, reviews generally advise gradual reduction, commonly limiting the mean arterial pressure reduction to no more than about 20–25% during the first few hours, rather than rapid normalization. The 2025 U.S. adult guideline expresses its general recommendation in systolic blood-pressure terms: for hypertensive emergencies without another condition-specific target, reduce systolic pressure by no more than 25% in the first hour; if the patient is stable, then lower it to below 160/100 mm Hg over the next 2–6 hours and cautiously toward 130–140 mm Hg over 24–48 hours. These general targets do not replace a stroke-specific pathway. If imaging identifies ischemic or hemorrhagic stroke, follow that syndrome’s blood-pressure pathway instead; the vignette alone cannot supply a final target.
The mechanism matters: longstanding hypertension can shift the brain’s autoregulatory range, so a sudden large pressure drop may compromise cerebral perfusion.
Coordinate calcineurin-inhibitor review; don’t treat the level as a verdict
Tacrolimus and cyclosporine can contribute to hypertension and neurologic toxicity, including seizures and PRES. Review the exact medication, recent dose changes, timing of the last dose, properly timed drug level, renal function, electrolytes, and possible interactions. A level within the intended range does not, by itself, rule out a contribution from the drug.
Contact the transplant team promptly to decide whether the calcineurin inhibitor should be held, reduced, or changed. A suspected drug contribution may require adjustment, but stopping or changing immunosuppression has graft-rejection implications and should be coordinated. Do not delay seizure stabilization or pressure management while waiting for a drug level.
The acute neurologic evaluation and planned tissue diagnosis answer different questions. Stabilize and investigate the new event now; whether the biopsy should be rescheduled is a separate decision for the teams managing the lesion and the transplant.
Practical takeaways
- Severe hypertension with a new seizure and reduced responsiveness is a possible neurologic hypertensive emergency, but the reading does not prove the cause.
- Consider PRES in transplant recipients taking calcineurin inhibitors; confirm or challenge that hypothesis with clinical assessment and imaging.
- Lower pressure in a monitored, controlled fashion; do not normalize it abruptly or apply a generic target if stroke or another specific emergency is found.
- Review calcineurin-inhibitor exposure with the transplant team. A therapeutic level does not settle the diagnosis, and unilateral medication changes can carry graft risk.
- Do not wait for biopsy to stabilize the patient or obtain urgent brain imaging.
